Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Osteoporosis International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s001980070051PMID 11148800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relief of osteoporotic backache with fluoride, calcium, and calciferol.

  2009cited by this paper
• Treatment of postmenopausal vertebral osteopenia with monofluorophospate: A long-term calcium-controlled study

  2005cited by this paper
• Discrepancies in normative data between Lunar and Hologic DXA systems

  2005cited by this paper
• Effect of fluoride dosage on bone density, sonic velocity, and longitudinal modulus of rabbit femurs

  2004cited by this paper
• Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

  1999cited by this paper
• Responsiveness of endpoints in osteoporosis clinical trials--an update.

  1999cited by this paper
• Avoidance of Vertebral Fractures in Men with Idiopathic Osteoporosis by a Three Year Therapy with Calcium and Low-Dose Intermittent Monofluorophosphate

  1998cited by this paper
• The Effect of Sodium Monofluorophosphate plus Calcium on Vertebral Fracture Rate in Postmenopausal Women with Moderate Osteoporosis

  1998cited by this paper
• Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy

  1998cited by this paper
• First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women.

  1997cited by this paper
• The Effect of Intermittent Slow-Release Sodium Fluoride and Continuous Calcium Citrate Therapy on Calcitropic Hormones, Biochemical Markers of Bone Metabolism, and Blood Chemistry in Postmenopausal Osteoporosis

  1997cited by this paper
• Responsiveness of endpoints in osteoporosis clinical trials.

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation.

  1996cited by this paper
• Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study

  1995cited by this paper
• Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects

  1995cited by this paper
• Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

  1995cited by this paper
• Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis

  1994cited by this paper
• Slow-Release Sodium Fluoride in the Management of Postmenopausal Osteoporosis

  1994cited by this paper
• Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations

  1994cited by this paper
• Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.

  1994cited by this paper
• Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

  1994cited by this paper
• [Evidence of fluoride-induced effects on the calcaneus by measurements of broadband ultrasound attenuation (BUA)].

  1994cited by this paper
• Measurement of intrinsic bone quality in vivo by reflection ultrasound: Correction of impaired quality with slow‐release sodium fluoride and calcium citrate

  1993cited by this paper
• A new fluoride preparation for the prevention of postmenopausal osteoporosis: calcium monofluorophosphate.

  1993cited by this paper
• Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site.

  1993cited by this paper
• Sodium fluoride-induced gastric mucosal lesions: comparison with sodium monofluorophosphate.

  1992cited by this paper
• X‐ray microanalysis of fluoride distribution in microfracture calluses in cancellous iliac bone from osteoporotic patients treated with fluoride and untreated

  1991cited by this paper
• The effect of sodium fluoride on trabecular architecture.

  1991cited by this paper
• Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.

  1991cited by this paper
• Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

  1990cited by this paper
• Fluoride therapy and parathyroid hormone activity in osteoporosis.

  1990cited by this paper
• Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride

  1989cited by this paper
• Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

  1988cited by this paper
• The effect of fluoride and calcium on spinal bone mineral content: A controlled, prospective (3 years) study

  1987cited by this paper
• Sodium fluoride in the treatment of osteoporosis.

  1986cited by this paper
• Long-term fluoride therapy of postmenopausal osteoporosis.

  1986cited by this paper
• Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics.

  1985cited by this paper
• Trabecular stress fractures during fluoride therapy for osteoporosis

  1985cited by this paper
• Extended treatment of primary osteoporosis by sodium fluoride combined with 25 hydroxycholecalciferol

  1984cited by this paper
• Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D.

  1982cited by this paper
• Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

  1982cited by this paper
• Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton.

  1981cited by this paper
• Effect of sodium fluoride, inorganic phosphate, and oxymetholone therapies in osteoporosis: a six-year progress report.

  1978cited by this paper
• [Fluoride therapy of osteoporosis].

  1976cited by this paper
• Letter: Prophylactic fluoride treatment and aged bones.

  1975cited by this paper
• Prophylactic fluoride treatment and aged bones.

  1975cited by this paper
• Three years' experience with sodium-fluoride therapy of osteoporosis.

  1974cited by this paper
• Fluoride and osteoporosis.

  1973cited by this paper
• Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis.

  1972cited by this paper
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females

  1971cited by this paper
• Effect of combined therapy with sodium fluoride, vitamin D, and calcium in osteoporosis.

  1971cited by this paper
• Effect of fluoride on human osteoporotic bone mineral. A chemical and crystallographic study.

  1966cited by this paper
• Effect of Sodium Fluoride on Calcium Metabolism of Human Beings

  1961cited by this paper

• Maternal serum polybrominated diphenyl ether concentrations during pregnancy and adolescent bone mineral density at age 12 years.

  2026cites this paper
• The associations between plasma fluoride and bone mass in children and adolescents

  2025influential citation
• Updated consumer risk assessment of fluoride in food and drinking water including the contribution from other sources of oral exposure

  2025cites this paper
• Associations between organophosphate esters and bone mineral density in adults in the United States: 2011-2018 NHANES.

  2024cites this paper
• Ion-chromatographic determination of common anions in drinking water in some regions of the Republic of Armenia

  2024cites this paper
• Evaluating Different Types of Treatment for Osteoporosis Using Fuzzy PROMETHEE

  2023cites this paper
• Diphenylpyrrole-Strapped Calix[4]pyrrole Extractant for the Fluoride and Chloride Anions.

  2023cites this paper
• Associations of urinary metabolite concentrations of phthalates and phthalate replacements with body composition from mid-childhood to early adolescence.

  2023cites this paper
• Fluoride contamination, consequences and removal techniques in water: a review

  2022cites this paper
• Non-Endemic Skeletal Fluorosis: Causes And Associated Secondary Hyperparathyroidism (Case Report and Literature Review).

  2021cites this paper
• Fluoride and Human Health

  2021cites this paper
• Denser but Not Stronger? Fluoride-Induced Bone Growth and Increased Risk of Hip Fractures

  2021cites this paper
• Associations of pregnancy phthalate concentrations and their mixture with early adolescent bone mineral content and density: The Health Outcomes and Measures of the Environment (HOME) study.

  2021cites this paper
• Factors governing the fluorination of hydroxyapatite by an ionic liquid

  2021cites this paper
• Fluoride in Drinking Water, Diet, and Urine in Relation to Bone Mineral Density and Fracture Incidence in Postmenopausal Women

  2021influential citation
• Fluoride Content in Drinking Water and the Health Implications of Fluoride-Rich Water Consumption: An Overview of the Situation in Canada and Nigeria

  2021cites this paper
• Fluoride and human health: Systematic appraisal of sources, exposures, metabolism, and toxicity

  2020cites this paper
• Increasing fluoride content deteriorates rat bone mechanical properties.

  2020cites this paper
• Etablierte Therapieoptionen bei postmenopausaler Osteoporose

  2019cites this paper
• Elemental analysis in living human subjects using biomedical devices

  2019cites this paper
• Biomechanical and Bone Material Properties of Schnurri‐3 Null Mice

  2019cites this paper
• CULTURAL PROPERTIES OF FUNGI OF THE FAMILY MUCORACEAE, THE GENUS ASPERGILLUS AS CAUSATIVE AGENTS OF ZOOANTHROPONOSIS

  2019cites this paper
• Regulatory Perspectives in Pharmacometric Models of Osteoporosis

  2018cites this paper
• Oleanolic Acid Exerts Osteoprotective Effects and Modulates Vitamin D Metabolism

  2018cites this paper
• THE USE OF VITAMINS AND MINERALS IN SKELETAL HEALTH: AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT.

  2018cites this paper
• Skeletal Fluorosis Due To Inhalation Abuse of a Difluoroethane‐Containing Computer Cleaner

  2017cites this paper
• Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease

  2017cites this paper
• Fluoride affects bone repair differently in mice models with distinct bone densities.

  2017cites this paper
• Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro

  2016cites this paper
• Effect of Sodium Fluoride on Bone Biomechanical and Histomorphometric Parameters and on Insulin Signaling and Insulin Sensitivity in Ovariectomized Rats

  2016cites this paper
• Spatial distribution mapping of drinking water fluoride levels in Karnataka, India: fluoride-related health effects

  2016cites this paper
• Structural characteristics and mechanisms of fluorapatite mechanochemical synthesis

  2016cites this paper
• Spatial distribution mapping of drinking water fluoride levels in Karnataka , India : fluoride-related health effects

  2016cites this paper
• Fluoride Exposure May Accelerate the Osteoporotic Change in Postmenopausal Women: Animal Model of Fluoride-induced Osteoporosis

  2016cites this paper
• Osteomalacia and rickets

  2015cites this paper
• Study of the changes in life cycle parameters of Drosophila melanogaster exposed to fluorinated insecticide, cryolite

  2015cites this paper
• Rapid‐Onset Diffuse Skeletal Fluorosis from Inhalant Abuse: A Case Report

  2014cites this paper
• Avaliação da sensibilidade insulínica, transdução do sinal insulínico e da densidade mineral óssea em ratas tratadas com fluoreto de sódio

  2014cites this paper
• Caracterização de um novo arcabouço de hidroxiapatita bifásica com a adsorção de fluoreto

  2014cites this paper
• Preparation, Characterization, and In Vitro Biological Evaluation of PLGA/Nano-Fluorohydroxyapatite (FHA) Microsphere-Sintered Scaffolds for Biomedical Applications

  2014cites this paper
• Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.

  2014cites this paper
• CPD diet and health Guidelines for fluoride intake

  2014cites this paper
• Investigation of Fluorine Incorporation within Gelatin/Calcium Phosphate Nanocomposite Scaffold Prepared through a Diffusion Method

  2013cites this paper
• Dental fluorosis and lumbar spine bone mineral density in adults, ages 20 to 49 years: results from the 2003 to 2004 National Health and Nutrition Examination Survey.

  2013cites this paper
• Mechanochemical and Low-Temperature Synthesis of Nanocrystalline Fluorohydroxyapatite/Fluorapatite

  2013cites this paper
• New precipitation method for synthesis of nano-fluorapatite

  2013cites this paper
• Improved prediction of rat cortical bone mechanical behavior using composite beam theory to integrate tissue level properties.

  2012cites this paper
• Effects of fluoride in bone repair: an evaluation of RANKL, OPG and TRAP expression

  2012cites this paper
• Pharmacological Treatment of Osteoporosis

  2012cites this paper
• Changes in Bone Quality of the Femoral Diaphysis Induced by High-Level Fluorine Ingestion in Ovariectomized Rats

  2012cites this paper
• Fluoride modulates preosteoblasts viability and matrix metalloproteinases-2 and -9 activities.

  2012cites this paper
• Position of the Academy of Nutrition and Dietetics: the impact of fluoride on health.

  2012cites this paper
• Electrolyte and Acid–Base Disorders

  2012cites this paper
• Finite Element 3D Modeling of Mechanical Behavior of Mineralized Collagen Microfibrils

  2011cites this paper
• Fluoride and Environmental Health

  2011cites this paper
• Calcium Fluoride/Hydroxyfluorapatite Nanocrystals as Novel Biphasic Solid Solution for Tooth Tissue Engineering and Regenerative Dentistry

  2011cites this paper
• Sedentary behavior enhances the loss of bone tissue quality induced by age and hypoestrogenemia.

  2011cites this paper
• Alkaline phosphatase activity in plasma and liver of rats submitted to chronic exposure to fluoride

  2011cites this paper
• Synthesis and solubility of calcium fluoride/hydroxy-fluorapatite nanocrystals for dental applications

  2011cites this paper
• Winning a Won Game: Caffeine Panacea for Obesity Syndemic

  2010cites this paper
• Screening for Osteoporosis

  2010cites this paper
• The paradox of overlapping micronutrient risks and benefits obligates risk/benefit analysis.

  2010cites this paper
• Effects of fluoride on cortical bone remodeling in regimens

  2010cites this paper
• Flúor: cáries, densidade mineral óssea e fraturas

  2010cites this paper
• Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

  2010cites this paper
• NOFSA Guideline for the Diagnosis and Management of Osteoporosis

  2010cites this paper
• Recombinant parathormone and osteoporosis: a review article

  2010cites this paper
• [Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making].

  2010cites this paper
• Flúor: cáries, densidade

  2009cites this paper
• Long-term therapeutic effect of novel calcium phosphate-based compounds injected in ovariectomized rats.

  2009cites this paper
• Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.

  2009cites this paper
• How close are we to having structure-modifying drugs available?

  2009cites this paper
• Hip Fractures and the Contribution of Cortical Versus Trabecular Bone to Femoral Neck Strength

  2009cites this paper
• Calcitonin and Fluoride

  2009cites this paper
• Fluoride and environmental health: a review

  2009cites this paper
• The comparison of powder characteristics and physicochemical, mechanical and biological properties between nanostructure ceramics of hydroxyapatite and fluoridated hydroxyapatite

  2009cites this paper
• Drug therapy of osteoporosis

  2008cites this paper
• Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats.

  2008cites this paper
• How close are we to having structure-modifying drugs available?

  2008cites this paper
• Detection of low bone mass using quantitative ultrasound measurements at calcaneus: comparative study of an Indian rheumatoid arthritis cohort

  2008cites this paper
• Studien mit Surrogatendpunkten

  2008cites this paper
• Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis

  2008influential citation
• Assessing the Methodological Quality of Systematic Reviews: The Development of AMSTAR

  2008cites this paper
• The effect of the microscopic and nanoscale structure on bone fragility

  2008cites this paper
• CHAPTER 69 – Evidence-Based Osteoporosis Care

  2008cites this paper
• Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.

  2007cites this paper
• Secondary osteoporosis during long-term steroid treatment

  2007cites this paper
• Synthesis of fluoride-releasing carbonate apatites for bone substitutes

  2007cites this paper
• Genetic background influences fluoride's effects on osteoclastogenesis.

  2007cites this paper
• Potentiometric measurement of ionic, acid-labile and covalently bound fluorine

  2007cites this paper
• Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?

  2006cites this paper
• Effect of systemic glucocorticoid therapy on bone metabolism: an update

  2006cites this paper
• TERIPARATIDA (1-34 hormona paratiroidea recombinante humana): un potente fármaco osteoformador para el tratamiento de la osteoporosis postmenopáusica.

  2006cites this paper
• The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.

  2006cites this paper
• Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment

  2006cites this paper
• The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis

  2006cites this paper
• Nutritionally Essential Minerals in Bone Health

  2006cites this paper
• Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.

  2006cites this paper
• Examining the Relationship Between Bone Mineral Density and Fracture Risk Reduction During Pharmacologic Treatment of Osteoporosis

  2006cites this paper
• Anabolic Agents for Osteoporosis

  2006cites this paper